Aldeyra Therapeutics (ALDX) Shares Outstanding (2013 - 2026)
Aldeyra Therapeutics (ALDX) Shares Outstanding (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Aldeyra Therapeutics | 93.19 Mn | 93.19 Mn | - | 60.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.32 Mn |
| Dec 31, 2025 | 60.06 Mn |
| Sep 30, 2025 | 60.13 Mn |
| Jun 30, 2025 | 60.05 Mn |
| Mar 31, 2025 | 59.89 Mn |
| Dec 31, 2024 | 59.48 Mn |
| Sep 30, 2024 | 59.53 Mn |
| Jun 30, 2024 | 59.41 Mn |
| Mar 31, 2024 | 59.41 Mn |
| Dec 31, 2023 | 58.94 Mn |
| Sep 30, 2023 | 58.99 Mn |
| Jun 30, 2023 | 58.79 Mn |
| Mar 31, 2023 | 58.79 Mn |
| Dec 31, 2022 | 58.41 Mn |
| Sep 30, 2022 | 58.46 Mn |
| Jun 30, 2022 | 58.30 Mn |
| Mar 31, 2022 | 58.30 Mn |
| Dec 31, 2021 | 54.04 Mn |
| Sep 30, 2021 | 58.02 Mn |
| Jun 30, 2021 | 54.28 Mn |